EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging role of natural lipophagy modulators in metabolic dysfunction–associated steatotic liver disease

Nahla E El-Ashmawy, Eman G Khedr, Ghada M Al-Ashmawy, Asmaa A Kamel

Nutrition · 2024

DOI: 10.1016/j.nut.2024.112517 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrition, 2024. Verfasst von Nahla E El-Ashmawy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt; Department of Pharmacology & Biochemistry, Faculty of Pharmacy, The …. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Autophagy, Lipid Metabolism, Liver. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 123 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is a seriously increasing liver disorder affecting nearly 32% of adults globally. Hepatic triglycerides (TG) accumulation is the hallmark of MASLD, which results from dysregulated lipid and fatty acid uptake, increased de novo lipogenesis (DNL), and decreased lipid removal. More recently, selective autophagy of lipid droplets (LDs), termed lipophagy, has emerged to be closely associated with disrupted hepatic lipid homeostasis. Recent studies have indicated that a series of natural products have shown promise as an alternative approach in attenuating MASLD via regulating lipophagy in vivo and in vitro. Therefore, lipophagy could be a new approach for natural products to be used to improve MASLD. This article aims to provide a comprehensive overview on the interrelationship between dysregulated lipid metabolism, lipophagy, and MASLD pathogenesis. In addition, the role of some natural products as lipophagy modulators and their impact on MASLD will be discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseAutophagyLipid MetabolismLiverBiological ProductsHumansAnimalsLipogenesisTriglyceridesLipid Droplets

Stichwörter der Autor:innen

AutophagyLipid dropletsLipophagyMASLDNAFLDNatural products

Substanzen

Biological ProductsTriglycerides

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt; Department of Pharmacology & Biochemistry, Faculty of Pharmacy, The British University in Egypt, El Sherouk, Cairo, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt; Department of Biochemistry, Faculty of Pharmacy, Al Salam University in Egypt, Kafr Az Zayat, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt. Electronic address: asmaa.kamel@pharm.tanta.edu.eg.

Zitieren

APA

El-Ashmawy, N. E., Khedr, E. G., Al-Ashmawy, G. M., & Kamel, A. A. (2024). Emerging role of natural lipophagy modulators in metabolic dysfunction–associated steatotic liver disease. Nutrition. https://doi.org/10.1016/j.nut.2024.112517

Vancouver

El-Ashmawy NE, Khedr EG, Al-Ashmawy GM, Kamel AA. Emerging role of natural lipophagy modulators in metabolic dysfunction–associated steatotic liver disease. Nutrition. 2024. doi:10.1016/j.nut.2024.112517

BibTeX
@article{ElAshmawy2024,
  author = {El-Ashmawy, Nahla E and Khedr, Eman G and Al-Ashmawy, Ghada M and Kamel, Asmaa A},
  title = {Emerging role of natural lipophagy modulators in metabolic dysfunction–associated steatotic liver disease},
  journal = {Nutrition},
  year = {2024},
  doi = {10.1016/j.nut.2024.112517}
}
Kostenlos starten →